Author:
Silkenstedt Elisabeth,Dreyling Martin,Rule Simon
Publisher
Springer International Publishing
Reference88 articles.
1. Banks PM, Chan J, Cleary ML, et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992;16(7):637–40.
2. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. In: Bosman FT, Jaffe ES, Lakhani SR, Ohgaki H, editors. World Health Organization classification of tumours. Revised 4th Edition, Volume 2.2. Lyon: IARC; 2017.
3. Dreyling M, Campo E, Hermine O, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(Suppl_4):iv62–71.
4. Naeim F. Atlas of hematopathology. Morphology, immunophenotype, cytogenetics and molecular approaches. 1st ed. New York: Academic Press; 2012. p. 411–25.
5. Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131(1):29–38.